Search results
Search for "isolation" in Full Text gives 983 result(s) in Beilstein Journal of Organic Chemistry. Showing first 200.
Synthesis of diaryl phosphates using phytic acid as a phosphorus source
- Kazuya Asao,
- Seika Matsumoto,
- Haruka Mori,
- Riku Yoshimura,
- Takeshi Sasaki,
- Naoya Hirata,
- Yasuyuki Hayakawa and
- Shin-ichi Kawaguchi
Beilstein J. Org. Chem. 2026, 22, 213–223, doi:10.3762/bjoc.22.15
- would be difficult. Furthermore, when 1-naphthol (1k) and 2-naphthol (1l) were used as substrates, the 31P NMR yields of the produced diesters were 45% (2k) and 29% (2l), respectively, and their isolation was difficult because of the presence of large amounts of naphthol-derived by-products. When the
- diaryl phosphate was isolated as a sodium salt, and the isolated yields are listed below. The yields in parentheses represent 31P nuclear magnetic resonance (NMR) yields defined based on a calibration curve using triphenylphosphine oxide as an internal standard. The isolation of 2c and 2j was not
Graphical Abstract
Scheme 1: Structure of phytic acid.
Figure 1: Structures of representative phosphate esters.
Figure 2: Synthetic methods for phosphorus compounds bypassing white phosphorus or phosphorus chloride.
Figure 3: Conditions for the syntheses of diaryl phosphates using phytic acid as a phosphorus source and scop...
Scheme 2: Phosphoric acid diesterification reaction conducted in a previous study.
Scheme 3: Scale-up reaction conducted for the time-course analysis of phosphate esterification. The reaction ...
Figure 4: Time-course analysis plots of the diphenylphosphate formation from phytic acid and 1a. The beginnin...
Figure 5: A possible reaction pathway for the formation of phosphate ester using phytic acid as the phosphoru...
Figure 6: 31P NMR spectrum of phytic acid extracted from rice bran.
Scheme 4: Esterification reaction conditions using the extracted phytic acid. The yield refers to the isolate...
Streptoquinolines A and B, new antibacterial meroterpenoids produced by Streptomyces sp. TMPU-A0679
- Akiho Yagi,
- Hitomi Tomura,
- Ami Konno and
- Ryuji Uchida
Beilstein J. Org. Chem. 2026, 22, 185–191, doi:10.3762/bjoc.22.12
- B (2) (Figure 1). Compounds 1 and 2 possessed a unique skeleton consisting of a drimane-type sesquiterpene fused with a quinoline moiety and both exhibited potent antibacterial activity against Gram-positive bacteria. This study describes the production, isolation, structural elucidation, and
- (Iwashiya Bio Science, Tokyo, Japan) at 180 rpm at 27 °C for 7 days. Isolation of compounds 1 and 2 The culture broth (6.0 L) was centrifuged to separate the mycelia and supernatant. Collected mycelia were treated with acetone (1.0 L) for 60 minutes. After suction filtration, the acetone solution was
Graphical Abstract
Figure 1: Structures of streptoquinolines A (1) and B (2).
Figure 2: Structural elucidation of compounds 1 and 2 by 2D NMR experiments.
Figure 3: ROESY correlations of 1.
Highly electrophilic, gem- and spiro-activated trichloromethylnitrocyclopropanes: synthesis and structure
- Ilia A. Pilipenko,
- Mikhail V. Grigoriev,
- Olga Yu. Ozerova,
- Igor A. Litvinov,
- Darya V. Spiridonova,
- Aleksander V. Vasilyev and
- Sergey V. Makarenko
Beilstein J. Org. Chem. 2026, 22, 123–130, doi:10.3762/bjoc.22.5
- were obtained using a MaXis mass spectrometer (Bruker Daltonik GmbH) equipped with an electrospray ionization source (4.5 eV) and a quadrupole time-of-flight analyzer (ESI–QTOF) in the positive ions detection mode, with methanol (0.1% FA [formic acid]) as solvent. Isolation of individual diastereomers
Graphical Abstract
Figure 1: Two natural trichloromethyl-containing compounds.
Scheme 1: Approaches to the synthesis of vic-trifluoromethylnitrocyclopropanes.
Scheme 2: Synthesis of monocyclic trichloromethylnitrocyclopropanes 2–5.
Scheme 3: Synthesis of spiro-fused trichloromethylnitrocyclopropane 6.
Scheme 4: Synthesis of spiro-fused trichloromethylnitrocyclopropanes 7–9. i: 1.5 AcOK, MeOH, rt, 3 h.
Scheme 5: Main NOE correlations in 9a, 9b.
Scheme 6: Proposed mechanism of the formation of trichloromethylnitrocyclopropanes.
Figure 2: Geometry of 2 in the crystal.
Figure 3: Geometry of 3 in the crystal.
Figure 4: Geometry of 9a in the crystal.
Figure 5: Geometry of 9b in the crystal.
Total synthesis of natural products based on hydrogenation of aromatic rings
- Haoxiang Wu and
- Xiangbing Qi
Beilstein J. Org. Chem. 2026, 22, 88–122, doi:10.3762/bjoc.22.4
- functional group manipulations, including a pivotal intramolecular SN2 cyclization, ultimately completing the total synthesis of (−)-senepodine F. Notably, this work also led to the structural revision of the originally assigned natural product, as reported in earlier isolation studies. Hydrogenation
Graphical Abstract
Scheme 1: The association between dearomatization and natural product synthesis.
Scheme 2: Key challenges in hydrogenation of aromatic rings.
Scheme 3: Hydrogenation of heterocyclic aromatic rings.
Scheme 4: Hydrogenation of the carbocyclic aromatic rings.
Scheme 5: Hydrogenation of the heterocycle part in bicyclic aromatic rings.
Scheme 6: Hydrogenation of the heterocycle part in bicyclic aromatic rings.
Scheme 7: Hydrogenation of benzofuran, indole, and their analogues.
Scheme 8: Hydrogenation of benzofuran, indole, and their analogues.
Scheme 9: Total synthesis of (±)-keramaphidin B by Baldwin and co-workers.
Scheme 10: Total synthesis of (±)-LSD by Vollhardt and co-workers.
Scheme 11: Total synthesis of (±)-dihydrolysergic acid by Boger and co-workers.
Scheme 12: Total synthesis of (±)-lysergic acid by Smith and co-workers.
Scheme 13: Hydrogenation of (−)-tabersonine to (−)-decahydrotabersonine by Catherine Dacquet and co-workers.
Scheme 14: Total synthesis of (±)-nominine by Natsume and co-workers.
Scheme 15: Total synthesis of (+)-nominine by Gin and co-workers.
Scheme 16: Total synthesis of (±)-lemonomycinone and (±)-renieramycin by Magnus.
Scheme 17: Total synthesis of GB13 by Sarpong and co-workers.
Scheme 18: Total synthesis of GB13 by Shenvi and co-workers.
Scheme 19: Total synthesis of (±)-corynoxine and (±)-corynoxine B by Xia and co-workers.
Scheme 20: Total synthesis of (+)-serratezomine E and the putative structure of huperzine N by Bonjoch and co-...
Scheme 21: Total synthesis of (±)-serralongamine A and the revised structure of huperzine N and N-epi-huperzin...
Scheme 22: Early attempts to indenopiperidine core.
Scheme 23: Homogeneous hydrogenation and completion of the synthesis.
Scheme 24: Total synthesis of jorunnamycin A and jorumycin by Stoltz and co-workers.
Scheme 25: Early attempt towards (−)-finerenone by Aggarwal and co-workers.
Scheme 26: Enantioselective synthesis towards (−)-finerenone.
Scheme 27: Total synthesis of (+)-N-methylaspidospermidine by Smith, Grigolo and co-workers.
Scheme 28: Dearomatization approach towards matrine-type alkaloids.
Scheme 29: Asymmetric total synthesis to (−)-senepodine F via an asymmetric hydrogenation of pyridine.
Scheme 30: Selective hydrogenation of indole derivatives and application.
Scheme 31: Synthetic approaches to the oxindole alkaloids by Qi and co-workers.
Scheme 32: Total synthesis of annotinolide B by Smith and co-workers.
Synthesis and applications of alkenyl chlorides (vinyl chlorides): a review
- Daniel S. Müller
Beilstein J. Org. Chem. 2026, 22, 1–63, doi:10.3762/bjoc.22.1
Graphical Abstract
Figure 1: Representative alkenyl chloride motifs in natural products. References: Pinnaic acid [8], haterumalide ...
Figure 2: Representative alkenyl chloride motifs in pharmaceuticals and pesticides. References: clomifene [25], e...
Figure 3: Graphical overview of previously published reviews addressing the synthesis of alkenyl chlorides.
Figure 4: Classification of synthetic approaches to alkenyl chlorides.
Scheme 1: Early works by Friedel, Henry, and Favorsky.
Scheme 2: Product distribution obtained by H NMR integration of crude compound as observed by Kagan and co-wo...
Scheme 3: Side reactions observed for the reaction of 14 with PCl5.
Scheme 4: Only compounds 15 and 18 were observed in the presence of Hünig’s base.
Scheme 5: Efficient synthesis of dichloride 15 at low temperatures.
Scheme 6: Various syntheses of alkenyl chlorides on larger scale.
Scheme 7: Scope of the reaction of ketones with PCl5 in boiling cyclohexane.
Scheme 8: Side reactions occur when using excess amounts of PCl5.
Scheme 9: Formation of versatile β-chlorovinyl ketones.
Scheme 10: Mixture of PCl5 and PCl3 used for the synthesis of 49.
Scheme 11: Catechol–PCl3 reagents for the synthesis of alkenyl chlorides.
Scheme 12: (PhO)3P–halogen-based reagents for the synthesis of alkenyl halides.
Scheme 13: Preparation of alkenyl chlorides from alkenyl phosphates.
Scheme 14: Preparation of alkenyl chlorides by treatment of ketones with the Vilsmeier reagent.
Scheme 15: Preparation of electron-rich alkenyl chlorides by treatment of ketones with the Vilsmeier reagent.
Scheme 16: Cu-promoted synthesis of alkenyl chlorides from ketones and POCl3.
Figure 5: GC yield of 9 depending on time and reaction temperature.
Figure 6: Broken reaction flask after attempts to clean the polymerized residue.
Figure 7: GC yield of 9 depending on the amount of CuCl and time.
Scheme 17: Treatment of 4-chromanones with PCl3.
Scheme 18: Synthesis of alkenyl chlorides from the reaction of ketones with acyl chlorides.
Scheme 19: ZnCl2-promoted alkenyl chloride synthesis.
Scheme 20: Regeneration of acid chlorides by triphosgene.
Scheme 21: Alkenyl chlorides from ketones and triphosgene.
Scheme 22: Various substitution reactions.
Scheme 23: Vinylic Finkelstein reactions reported by Evano and co-workers.
Scheme 24: Challenge of selective monohydrochlorination of alkynes.
Scheme 25: Sterically encumbered internal alkynes furnish the hydrochlorination products in high yield.
Scheme 26: Recent work by Kropp with HCl absorbed on alumina.
Scheme 27: High selectivities for monhydrochlorination with nitromethane/acetic acid as solvent.
Figure 8: Functionalized alkynes which typically afford the monhydrochlorinated products.
Scheme 28: Related chorosulfonylation and chloroamination reactions.
Scheme 29: Reaction of organometallic reagents with chlorine electrophiles.
Scheme 30: Elimination reactions of dichlorides to furnish alkenyl chlorides.
Scheme 31: Elimination reactions of allyl chloride 182 to furnish alkenyl chloride 183.
Scheme 32: Detailed studies by Schlosser on the elimination of dichloro compounds.
Scheme 33: Stereoselective variation caused by change of solvent.
Scheme 34: Elimination of gem-dichloride 189 to afford alkene 190.
Scheme 35: Oxidation of enones to dichlorides and in situ elimination thereof.
Scheme 36: Oxidation of allylic alcohols to dichlorides and in situ elimination thereof.
Scheme 37: Chlorination of styrenes with SOCl2 and elimination thereof.
Scheme 38: Chlorination of styrenes with SOCl2 and elimination thereof.
Scheme 39: Fluorine–chlorine exchange followed by elimination.
Scheme 40: Intercepting cations with alkynes and trapping of the alkenyl cation intermediate with chloride.
Scheme 41: Investigations by Mayr and co-workers.
Scheme 42: In situ activation of benzyl alcohol 230 with BCl3.
Scheme 43: In situ activation of benzylic alcohols with TiCl4.
Scheme 44: In situ activation of benzylic alcohols with FeCl3.
Scheme 45: In situ activation of benzylic alcohols with FeCl3.
Scheme 46: In situ activation of aliphatic chlorides and alcohols with ZnCl2, InCl3, and FeCl3.
Scheme 47: In situ generation of benzylic cations and trapping thereof with alkynes.
Scheme 48: Intramolecular trapping reactions affording alkenyl halides.
Scheme 49: Intramolecular trapping reactions affording alkenyl chlorides.
Scheme 50: Intramolecular trapping reactions of oxonium and iminium ions affording alkenyl chlorides.
Scheme 51: Palladium and nickel-catalyzed coupling reactions to afford alkenyl chlorides.
Scheme 52: Rhodium-catalyzed couplings of 1,2-trans-dichloroethene with arylboronic esters.
Scheme 53: First report on monoselective coupling reactions for 1,1-dichloroalkenes.
Scheme 54: Negishi’s and Barluenga’s contributions.
Scheme 55: First mechanistic investigation by Johnson and co-workers.
Scheme 56: First successful cross-metathesis with choroalkene 260.
Scheme 57: Subsequent studies by Johnson.
Scheme 58: Hoveyda and Schrock’s work on stereoretentive cross-metathesis with molybdenum-based catalysts.
Scheme 59: Related work with (Z)-dichloroethene.
Scheme 60: Further ligand refinement and traceless protection of functional groups with HBpin.
Scheme 61: Alkenyl chloride synthesis by Wittig reaction.
Scheme 62: Alkenyl chloride synthesis by Julia olefination.
Scheme 63: Alkenyl chloride synthesis by reaction of ketones with Mg/TiCl4 mixture.
Scheme 64: Frequently used allylic substitution reactions which lead to alkenyl chlorides.
Scheme 65: Enantioselective allylic substitutions.
Scheme 66: Synthesis of alkenyl chlorides bearing an electron-withdrawing group.
Scheme 67: Synthesis of α-nitroalkenyl chlorides from aldehydes.
Scheme 68: Synthesis of alkenyl chlorides via elimination of an in situ generated geminal dihalide.
Scheme 69: Carbenoid approach reported by Pace.
Scheme 70: Carbenoid approach reported by Pace.
Scheme 71: Ring opening of cyclopropenes in the presence of MgCl2.
Scheme 72: Electrophilic chlorination of alkenyl MIDA boronates to Z- or E-alkenyl chlorides.
Scheme 73: Hydroalumination and hydroboration of alkynyl chlorides.
Scheme 74: Carbolithiation of chloroalkynes.
Scheme 75: Chlorination of enamine 420.
Scheme 76: Alkyne synthesis by elimination of alkenyl chlorides.
Scheme 77: Reductive lithiation of akenyl chlorides.
Scheme 78: Reactions of alkenyl chlorides with organolithium reagents.
Scheme 79: Reactions of alkenyl chlorides with organolithium reagents.
Scheme 80: Addition–elimination reaction of alkenyl chloride 9 with organolithium reagents.
Scheme 81: C–H insertions of lithiumcarbenoids.
Scheme 82: Pd-catalyzed coupling reactions with alkenyl chlorides as coupling partner.
Scheme 83: Ni-catalyzed coupling of alkenylcopper reagent with alkenyl chloride 183.
Scheme 84: Ni-catalyzed coupling of heterocycle 472 with alkenyl chloride 473.
Scheme 85: Synthesis of α-chloroketones by oxidation of alkenyl chlorides.
Scheme 86: Tetrahalogenoferrate(III)-promoted oxidation of alkenyl chlorides.
Scheme 87: Chlorine–deuterium exchange promoted by a palladium catalyst.
Scheme 88: Reaction of alkenyl chlorides with thiols in the presence of AIBN (azobisisobutyronitrile).
Scheme 89: Chloroalkene annulation.
One-pot synthesis of ethylmaltol from maltol
- Immanuel Plangger,
- Marcel Jenny,
- Gregor Plangger and
- Thomas Magauer
Beilstein J. Org. Chem. 2025, 21, 2755–2760, doi:10.3762/bjoc.21.212
- , needles, and bark of certain trees. In particular, the bark of larch trees contains 0.1–2 wt % maltol (2) and economic isolation methods using for example aqueous tannin liquors with extraction efficiencies of >90% have been developed [22][23][24]. Owing to the natural availability of maltol (2
Graphical Abstract
Scheme 1: Importance and synthetic approaches to ethylmaltol (1). (a) Ethylmaltol (1) is widely used as a fla...
Scheme 2: Optimized one-pot procedure to access ethylmaltol (1) via a transient protecting group strategy.
Total synthesis of asperdinones B, C, D, E and terezine D
- Ravi Devarajappa and
- Stephen Hanessian
Beilstein J. Org. Chem. 2025, 21, 2730–2738, doi:10.3762/bjoc.21.210
- activity [20]. A related metabolite lacking the C7 prenyl group had been isolated from the cultures of Aspergillus chevalieri in 1976 [21]. The structure and absolute stereochemistry were confirmed by synthesis from tryptophan and ʟ-alanine [22]. The isolation of terezine D (6) and more recently, the (3R
Graphical Abstract
Figure 1: Structures of prenylindole alkaloids derived from tryptophan.
Figure 2: Representative retrosynthetic considerations for 7-prenyl- and 7-allyltryptophan.
Scheme 1: C-7 Functionalization of 7-iodo-Nα-Boc-tryptophan methyl ester.
Scheme 2: C-7 Prenylation via C–H activation.
Figure 3: Negishi cross-coupling of allyl- and prenyl(iodo)indoles.
Scheme 3: Synthesis of prenyl- and allylindoles.
Scheme 4: Markovnikov hydrochlorination and hydrotrifluoroacetylation.
Scheme 5: Synthesis of asperdinones B–E 1–4.
Scheme 6: Control experiment.
Scheme 7: Control experiment of the Negishi cross-coupling reaction.
Scheme 8: Synthesis of terezine D and ent-asperdinone E.
Recent advancements in the synthesis of Veratrum alkaloids
- Morwenna Mögel,
- David Berger and
- Philipp Heretsch
Beilstein J. Org. Chem. 2025, 21, 2657–2693, doi:10.3762/bjoc.21.206
- subclass The cevanine-type alkaloids constitute the largest of the three subgroups of Veratrum alkaloids. However, they have long withstood the efforts of total synthesis endeavors, perhaps owing to their typically densely functionalized hexacyclic framework. To date, the isolation of at least 80 different
- isolation of heilonine was reported in 1989 by Kaneko et al. from Fritillaria ussuriensis. It is believed to be a constituent of “beimu", a traditional Chinese medicine that is used as a sedative, antitussive, and expectorant [52]. The nine stereocenters reside in two different regions of the molecule
Graphical Abstract
Scheme 1: Representatives of steroid alkaloid classes. Marked in blue is the steroidal cholestane framework, ...
Scheme 2: Subclasses of Veratrum alkaloids: jervanine, veratramine and cevanine-type [8].
Scheme 3: Flow chart presentation of the synthesis of (−)-englerin A developed by the Christmann group [10].
Scheme 4: Structures and year of synthesis of the three types of Veratrum alkaloids reported in the literatur...
Scheme 5: Key step in the synthesis of cyclopamine (6) by the Giannis group [21].
Scheme 6: Overview of the semisynthesis of cyclopamine (6) reported by the Giannis group in 2009 [21].
Scheme 7: Key steps in the synthesis of cyclopamine (6) by the Baran group [23].
Scheme 8: Overview of the total synthesis of cyclopamine (6) by the Baran group in 2023 [23].
Scheme 9: Key steps in the synthesis of cyclopamine (6) by the Zhu/Gao group [25].
Scheme 10: Overview of the total synthesis of cyclopamine (6) by the group of Zhao/Gao in 2023 [25].
Scheme 11: Key steps in the synthesis of cyclopamine (6) by the Liu/Qin group [26].
Scheme 12: Overview of the semisynthesis of cyclopamine (6) by the Liu/Qin group in 2024 [26].
Scheme 13: Key steps in the synthesis of jervine (12) by the Masamune group [14].
Scheme 14: Overview of the total synthesis of jervine (12) by the Masamune group in 1968 [14].
Scheme 15: Color-coded schemes of the presented cyclopamine (6) syntheses by Giannis, Baran, Zhu/Gao, and Liu/...
Scheme 16: Key steps in the total synthesis of veratramine (13) by the Johnson group [15].
Scheme 17: Overview of the total synthesis of veratramine (13) by the Johnson group in 1967 [15].
Scheme 18: Key steps in the synthesis of veratramine (13) by the Zhu/Gao group [25].
Scheme 19: Shortened overview of the total synthesis of veratramine (13) by the Zhu/Gao group in 2023 [25].
Scheme 20: Key steps in the synthesis of veratramine by the Liu/Qin group [26].
Scheme 21: Overview of the semisynthesis of veratramine (13) by the Liu/Qin group in 2024 [26].
Scheme 22: Key steps in the synthesis of veratramine (13) by the Trauner group [27].
Scheme 23: Overview of the total synthesis of veratramine (13) by the Trauner group in 2025 [27].
Scheme 24: Key steps in the synthesis of verarine (14) by the Kutney group [16-19].
Scheme 25: Overview of the total synthesis of verarine (14) by the Kutney group reported 1962–1968 [16-19].
Scheme 26: Color-coded schemes of the presented veratramine-type alkaloid synthesis of Zhu/Gao, Liu/Qin and Tr...
Scheme 27: Structures of veracevine (86), veratridine (87), and cevadine (88).
Scheme 28: Key step in the semisynthesis of verticine (15) by the Kutney group (1977) [20,46].
Scheme 29: Overview of the semisynthesis of verticine (15) by the Kutney group (1977) [20,46].
Scheme 30: Key step of the total synthesis of (±)-4-methylenegermine (17) by the Stork group (2017) [22].
Scheme 31: Overview of the total synthesis of (±)-4-methylenegermine (17) by the Stork group (2017) [22].
Scheme 32: Key step of the total synthesis of heilonine (16) by Cassaidy and Rawal (2021) [24].
Scheme 33: Overview of the total synthesis of heilonine (16) by Cassaidy and Rawal (2021) [24]. FGI: functional gr...
Scheme 34: Key steps of the synthesis of heilonine (16) by Dai and co-workers (2024) [28].
Scheme 35: Overview of the total synthesis of heilonine (16) by Dai and co-workers (2024) [28].
Scheme 36: Key steps of the total synthesis of zygadenine (18) reported by Luo and co-workers [29].
Scheme 37: Overview of the total synthesis of zygadenine (18) by Luo and co-workers (2023) [29].
Scheme 38: Key step of the divergent total syntheses of highly oxidized cevanine-type alkaloids by Luo and co-...
Scheme 39: Divergent syntheses of highly oxidized cevanine-type alkaloids by Luo and co-workers (2024) [30].
Scheme 40: Color-coded overview of the presented cevanine-type alkaloid syntheses [10,20,22,24,28-30,46]. LLS: longest linear sequen...
Thiazolidinones: novel insights from microwave synthesis, computational studies, and potentially bioactive hybrids
- Luan A. Martinho,
- Victor H. J. G. Praciano,
- Guilherme D. R. Matos,
- Claudia C. Gatto and
- Carlos Kleber Z. Andrade
Beilstein J. Org. Chem. 2025, 21, 2618–2636, doi:10.3762/bjoc.21.203
- ), delivers excellent yields (up to 99%), and requires a low catalyst loading (10 mol %). The reactions are fast and can be applied to a wide range of aromatic and heteroaromatic aldehydes, with product isolation achieved by the simple addition of an aqueous HCl solution. This methodology was successfully
Graphical Abstract
Figure 1: Structure of thiazolidinone derivatives.
Figure 2: Selected examples of commercial drugs containing the thiazolidinone core.
Scheme 1: Multicomponent reaction of benzaldehyde, rhodanine, and piperidine in ethanol leading directly to a...
Scheme 2: Substrate scope of the EDA-catalyzed Knoevenagel condensation reactions using a range of aromatic/h...
Scheme 3: Limitations of the EDA-catalyzed Knoevenagel reactions for the synthesis of rhodanine or thiazolidi...
Scheme 4: Plausible reaction mechanism for the EDA-catalyzed Knoevenagel condensation reactions.
Scheme 5: Substrate scope of the HPW-catalyzed GBB reactions.
Scheme 6: Synthesis of imidazo[1,2-a]pyridine-thiazolidinone hybrids by EDA-catalyzed Knoevenagel condensatio...
Figure 3: Overlay of predicted (red) and experimental (black) NMR spectra for compound 3n: a) 1H NMR spectra ...
Figure 4: a) Molecular structure of 3n with crystallographic labeling (50% probability displacement). b) Pers...
Scheme 7: a) Tautomeric forms of thiazolidinones and b) resonance structures for compounds 3n and 4n.
Figure 5: Molecular energy as a function of the torsion angle obtained from a relaxed dihedral scan at the M0...
Figure 6: Identification of the carbon atoms used in the theoretical study of chemical shifts. In red, easily...
Figure 7: a) Visual impressions of the solvatochromic study in various solvents (10−5 M) after excitation wit...
Scheme 8: Proposed ICT-type mechanism for the fluorescence process, adapted from ref. [89].
Figure 8: Photophysical study in aqueous solution under different pH values for compound 3n (10−5 M) at room ...
Scheme 9: Two equilibria of compound 3n in aqueous solutions, adapted from ref. [92,93].
Figure 9: Molecular fragments associated with intramolecular charge transfer states.
Figure 10: Frontier molecular orbitals of compounds 3n and 4n in three different states: protonated, deprotona...
Efficient solid-phase synthesis and structural characterization of segetalins A–H, J and K
- Liangyu Liu,
- Wanqiu Lu,
- Quanping Guo and
- Zhaoqing Xu
Beilstein J. Org. Chem. 2025, 21, 2612–2617, doi:10.3762/bjoc.21.202
- , culminating in cyclization mediated by N,N'-dicyclohexylcarbodiimide (DCC)/N-methylmorpholine (NMM) at 0 °C for 7 days [18]. This method, however, is lengthy, operationally complex, difficult for product isolation, and carries a significant risk of racemization. Wong and Jolliffe synthesized segetalins B (2
Graphical Abstract
Scheme 1: Preparation of segetalins A–H, J and K.
Figure 1: Cyclization reactions to segetalins A–H, J and K.
Figure 2: The CD spectra of segetalins A–H, J and K.
Recent advances in total synthesis of illisimonin A
- Juan Huang and
- Ming Yang
Beilstein J. Org. Chem. 2025, 21, 2571–2583, doi:10.3762/bjoc.21.199
- embellished by additional bridging via a γ-lactone and a γ-lactol ring, resulting in a caged pentacyclic scaffold with a 5/5/5/5/5 ring arrangement. The compound demonstrates neuroprotective activity by mitigating oxygen-glucose deprivation-induced cell injury in SH-SY5Y cells. Since its isolation in 2017
- , illisimonin A has garnered significant interest from the synthetic chemistry community. To date, five research groups have accomplished the total synthesis of illisimonin A. This review offers a comprehensive overview of its isolation, proposed biosynthetic pathway and the synthetic strategies employed in its
- have been isolated from this genus, among which Illicium sesquiterpenes represent a prominent group. Since the first isolation of anisatin in 1952 [1], more than 100 Illicium sesquiterpenes have been isolated from over 40 species of Illicium [2]. Based on their carbon skeletons, they can be classified
Graphical Abstract
Figure 1: The categorization of Illicium sesquiterpenes and representative natural products.
Figure 2: The original assigned (−)-illisimonin A, revised (−)-illisimonin A, and their different draws.
Scheme 1: Proposed biosynthetic pathway of illisimonin A by Yu et al.
Scheme 2: Rychnovsky’s racemic synthesis of illisimonin A (1).
Scheme 3: The absolute configuration revision of (−)-illisimonin A.
Scheme 4: Kalesse’s asymmetric synthesis of (−)-illisimonin A.
Scheme 5: Yang group proposed biosynthetic pathway of illisimonin A.
Scheme 6: Yang’s bioinspired synthesis of illisimonin A.
Scheme 7: Dai’s asymmetric synthesis of (–)-illisimonin A.
Scheme 8: Lu’s total synthesis of illisimonin A.
Scheme 9: Initial efforts toward the total synthesis of illisimonin A by the Lu Group.
Scheme 10: Suzuki’s synthetic effort towards illisimonin A.
Total syntheses of highly oxidative Ryania diterpenoids facilitated by innovations in synthetic strategies
- Zhi-Qi Cao,
- Jin-Bao Qiao and
- Yu-Ming Zhao
Beilstein J. Org. Chem. 2025, 21, 2553–2570, doi:10.3762/bjoc.21.198
- ]. Research on these compounds dates back to 1943 when the American pharmaceutical company Merck developed a novel insecticide, Ryanex, from the stems and leaves of the plant. In 1948, Folkers and colleagues reported the isolation of the first bioactive member of this family – ryanodine (1) [8]. Due to
- scaffold yet exhibit diverse oxidation patterns and stereochemical configurations, with ryanodine (1) representing a landmark example (Table 1). This review has highlighted synthetic investigations of Ryania diterpenoids by various research groups, encompassing brief discussions of their isolation
Graphical Abstract
Scheme 1: Representative Ryania diterpenoids and their derivatives.
Scheme 2: Deslongchamps’s total synthesis of ryanodol (4).
Scheme 3: Deslongchamps’s total synthesis of 3-epi-ryanodol (5).
Scheme 4: Inoue’s total synthesis of ryanodol (4).
Scheme 5: Inoue’s total synthesis of ryanodine (1) from ryanodol (4).
Scheme 6: Inoue’s total synthesis of cinncassiol A (9), cinncassiol B (7), cinnzeylanol (6), and 3-epi-ryanod...
Scheme 7: Reisman’s total synthesis of (+)-ryanodol (4).
Scheme 8: Reisman’s total synthesis of (+)-ryanodine (1) and (+)-20-deoxyspiganthine (2).
Scheme 9: Micalizio’s formal total synthesis of ryanodol (4).
Scheme 10: Zhao’s total synthesis of garajonone (8).
Scheme 11: Zhao’s formal total synthesis of ryanodol (4) and ryanodine (1).
Assembly strategy for thieno[3,2-b]thiophenes via a disulfide intermediate derived from 3-nitrothiophene-2,5-dicarboxylate
- Roman A. Irgashev
Beilstein J. Org. Chem. 2025, 21, 2489–2497, doi:10.3762/bjoc.21.191
- isolation of compounds 2 and 3 in analytically pure form allowed their structure to be established thanks to elemental analysis and HRMS. It was found that compounds 2 and 3 are dimeric derivatives of the starting thiophene, linked by sulfur bridges located at the C-3 position instead of the nitro group
Graphical Abstract
Scheme 1: The synthetic routes to 3-hydroxy-substituted TT derivatives.
Scheme 2: The present retrosynthetic plan for constructing TT molecules.
Scheme 3: An attempt to nucleophilically substitute the NO2 group in ester 1.
Scheme 4: The reaction of ester 1 with potassium thioacetate.
Scheme 5: A probable mechanism for the formation of compounds 2 and 3.
Scheme 6: The synthesis of 3-(alkylthio)thiophene-2,5-dicarboxylates 4–6, yields, and scope of products. *Fro...
Scheme 7: The synthesis of TT derivatives, yields, and scope of products. Conditions: i) LiH (5 equiv), DMF, ...
Transformation of the cyclohexane ring to the cyclopentane fragment of biologically active compounds
- Natalya Akhmetdinova,
- Ilgiz Biktagirov and
- Liliya Kh. Faizullina
Beilstein J. Org. Chem. 2025, 21, 2416–2446, doi:10.3762/bjoc.21.185
- KMnO4 in EtOH at 0 °C afforded vicinal diol 20 with a yield of 58%. The periodate cleavage of the latter under the action of NaIO4 led to the formation of a labile dialdehyde, which was treated with t-BuOK in THF without isolation. As a result of intramolecular aldol condensation, accompanied by the
- led to the isolation of alcohol 138 with a yield of 52%. The Wolff rearrangement was carried out upon irradiation of a solution of mesylate 139 in THF at 25 °C with a medium-pressure Hg lamp for 1 hour. The ring contraction proceeded diastereoselectively and the desired acid 140 was obtained as a
- 10 μg/mL). Sequential interaction of indole 219 with pyridinium p-toluenesulfonate (PPTS) and excess of Davis’ oxaziridine 222, an effective oxidizing agent for synthesis of spirooxindole alkaloids, led to epoxide 220. Labile oxirane 220, without isolation, was subjected to a semipinacol
Graphical Abstract
Scheme 1: Ozonolysis–cyclization sequence in the synthesis of echinopine A (3).
Scheme 2: Ozonolysis–cyclization sequence in the synthesis of taiwaniaquinoids 7–12.
Figure 1: Iridoid skeleton.
Scheme 3: Ozonolysis–cyclization sequence in the synthesis of compounds 17a,b, 18 and 19 with iridoid topolog...
Scheme 4: Oxidation–aldol condensation sequence in the synthesis of compounds 21 and 23 with iridoid topology....
Scheme 5: Oxidation–aldol condensation sequence in the synthesis of compounds 29 and 30 with iridoid topology....
Scheme 6: Method for ring contraction in the absence of a double bond in a six-membered ring of triterpenoids....
Scheme 7: Oxidation–Dieckmann cyclization sequence in the synthesis of a new nortriterpenoid 39.
Scheme 8: Oxidation–Dieckmann cyclization sequence in the synthesis of 18,19-di-nor-cholesterol (40).
Scheme 9: Oxidation–cyclization sequence in the synthesis of 3-ethyl-substituted betulinic acid derivatives 49...
Scheme 10: Benzilic acid-type rearrangement in the synthesis of 4β-acetoxyprobotryane-9β,15α-diol (52).
Scheme 11: Benzilic acid-type rearrangement in the synthesis of (−)-taiwaniaquinone H (11).
Scheme 12: Benzilic acid-type rearrangement in the synthesis of dactylicapnosines A (63) and B (64).
Scheme 13: Aza-benzilic acid-type rearrangement in the synthesis of (+)-stephadiamine (71).
Scheme 14: α-Ketol rearrangement in the synthesis of saffloneoside (73).
Scheme 15: Conversion of (−)-preaustinoid A (80) to (−)-preaustinoid B (81) via α-ketol rearrangement.
Scheme 16: α-Ketol rearrangement in the synthesis of 2,8-oxymethano-bridged diquinane 90.
Scheme 17: Oxidative ring contraction during the synthesis of (+)-cuparene (91) and (+)-tochuinylacetate (92).
Scheme 18: Semipinacol rearrangement in the synthesis of diterpenoids 97–100.
Scheme 19: Co-catalyzed homoallyl-type rearrangement in the syntheses of meroterpenes 106–109.
Scheme 20: Ring contraction reaction promoted by TTN·3H2O and HTIB in the synthesis of indanes.
Scheme 21: Rearrangement involving a hypervalent iodine compound in the synthesis of derivative 120.
Scheme 22: Wolff rearrangement in the synthesis of taiwaniaquinones A (7), F (8), taiwaniaquinols B (10), D (1...
Scheme 23: Wolff rearrangement in the synthesis of cheloviolene C (128), seconorrisolide B (129), and seconorr...
Scheme 24: Wolff rearrangement in the synthesis of (−)-pavidolide B (134).
Scheme 25: Wolff rearrangement in the synthesis of presilphiperfolan-8-ol (141).
Scheme 26: Photochemical rearrangement in the synthesis of cyclopentane derivatives 147a,b.
Scheme 27: Synthesis of cyclopentane derivatives 147a and 151.
Scheme 28: Photochemical rearrangement in the synthesis of cyclopentane derivative 153.
Scheme 29: Photochemical rearrangement in the synthesis of tricyclic ketones 155, 156.
Scheme 30: Photochemical rearrangement in the synthesis of cis/trans salts 160.
Figure 2: Scope of the photoinduced carboborative ring contraction of steroids. Reaction conditions: steroid ...
Scheme 31: Photoinduced carboborative ring contraction in the synthesis of artalbic acid (180).
Scheme 32: Synthetic versatility of the photoinduced carboborative ring contraction.
Scheme 33: Methods of disclosure of epoxide 189.
Scheme 34: Methods of disclosure of epoxide 190.
Scheme 35: Rearrangement of α,β-epoxy ketone 197.
Scheme 36: Acid-induced rearrangement in the synthesis of perhydrindane ketones 202 and 205.
Scheme 37: Rearrangement of epoxyketone 208 in the synthesis of huperzine Q (206).
Scheme 38: Rearrangement of epoxide 212 under the action of Grignard reagent.
Scheme 39: Semipinacol rearrangement of epoxide 220 in the synthesis of (−)-citrinadin A (217) and (+)-citrina...
Scheme 40: Semipinacol rearrangement of epoxide 225 in the synthesis of hamigeran G (223).
Scheme 41: Semipinacol rearrangement of epoxide 231 in the synthesis of (−)-spirochensilide A (228).
Scheme 42: Wagner–Meerwein rearrangement in the synthesis of compound 234 with iridoid topology.
Scheme 43: Wagner–Meerwein rearrangement in the synthesis of compound 238 with iridoid topology.
Scheme 44: Wagner–Meerwein rearrangement in the synthesis of compound 241 with iridoid topology.
Scheme 45: Wagner–Meerwein rearrangement in the synthesis of lupane derivatives 245, 246, 248, and 249.
Scheme 46: Wagner–Meerwein rearrangement in the synthesis of weisaconitine D (252) and cardiopetaline (255).
Scheme 47: Wagner–Meerwein rearrangement in the synthesis of cardiopetaline (255).
The high potential of methyl laurate as a recyclable competitor to conventional toxic solvents in [3 + 2] cycloaddition reactions
- Ayhan Yıldırım and
- Mustafa Göker
Beilstein J. Org. Chem. 2025, 21, 2389–2415, doi:10.3762/bjoc.21.184
- solvent medium for the reaction, and the related compounds were obtained through straightforward isolation techniques in a relatively short time frame (5–80 minutes). A comprehensive investigation was conducted utilizing various web platforms, encompassing ecological and environmental risk assessments
- a promising biocompatible solvent alternative in numerous chemical transformations, there are several challenges associated with product isolation that must be addressed [23]. Consequently, it is evident that the endeavor to identify an optimal green solvent for both industrial and academic
- in the isolation of the cycloadduct through precipitation, given that castor oil is insoluble in hexane. The solvent dissolves the product together with castor oil, causing it to pass to the filtrate phase and thereby reducing the amount present. In order to remain faithful to the principles of Green
Graphical Abstract
Figure 1: Versatile compounds via cycloaddition reactions.
Scheme 1: Molecular structures of parent compounds 1a–f, 2a–d and cycloadducts 3a–u.
Figure 2: a) Radar view of the physical properties of methyl laurate. b) Oral toxicity values of methyl laura...
Figure 3: The oral toxicity values of all the solvents utilized in the present study obtained with ProTox 3.0....
Figure 4: Ecological, environmental risk assessments, pesticide similarity and biodegradability assessments o...
Figure 5: Ecological, environmental risk assessments, pesticide similarity and biodegradability assessments o...
Figure 6: Ecological, environmental risk assessments, pesticide similarity and biodegradability assessments o...
Figure 7: Various toxicity parameters of methyl laurate and a series of other solvents calculated by ADMETLab...
Figure 8: a) Visualization of the localization of conventional organic and bio-based solvents in the Hansen s...
Figure 9: Vapour pressures of the solvents used (values retrieved from the Chemeo molecular database).
Scheme 2: Endo and exo stereoisomeric approaches of nitrone 1a and maleimide 2a in [3 + 2] cycloaddition reac...
Figure 10: Signals of protons used in the calculation of the diastereomeric ratios (cis/trans) of cycloadditio...
Figure 11: Results of studies on the recovery of solvents used in the reaction.
Figure 12: Simplified scheme describing the reaction monitoring and solvent recovery.
Figure 13: a) The superimposed spectra of C,N-diphenylnitrone and N-phenylmaleimide. b) The spectrum of methyl...
Rotaxanes with integrated photoswitches: design principles, functional behavior, and emerging applications
- Jullyane Emi Matsushima,
- Khushbu,
- Zuliah Abdulsalam,
- Udyogi Navodya Kulathilaka Conthagamage and
- Víctor García-López
Beilstein J. Org. Chem. 2025, 21, 2345–2366, doi:10.3762/bjoc.21.179
- property, in addition to facilitating their study and isolation, is advantageous for various applications. The first stiff-stilbene-based rotaxane was reported in 2018 [79]. This [1]rotaxane used stiff-stilbene as one of the stoppers, and its photoisomerization produced the translation of a pillar[5]arene
Graphical Abstract
Figure 1: Schematic of common rotaxanes (left) and depiction of the macrocycle shuttling (right).
Figure 2: Structure of some common photoswitches integrated into rotaxanes.
Figure 3: Rotaxane with an acridane photoswitch on the axle modulates the translation of a CBQT4+ macrocycle ...
Figure 4: Hydrogel composed of [2]rotaxanes featuring a central azobenzene in the axle and a cyclodextrin mac...
Figure 5: Dendrimer composed of [2]rotaxane with an azobenzene photoswitch functioning as a macroscopic actua...
Figure 6: (a) Structure of the [2]rotaxane and (b) mechanism for K+ cations transport across lipid bilayers. Figure 6...
Figure 7: Dithienylethene-based [2]rotaxane used in writing patterning applications: (a) rotaxane with open d...
Figure 8: Dithienylethene-based [1]rotaxane shuttling motion triggered by pH changes (top). Dithienylethene p...
Figure 9: Depiction of a fumaramide-based [2]rotaxane photoswitching cycle and deposition on glass and mica s...
Figure 10: Hydrazone-based rotaxane controls helical pitch in a liquid crystal. Figure 10 was adapted from [73] (© 2024 S. ...
Figure 11: (a) Light- and pH-responsive Förster resonance energy transfer observed on a spiropyran-based [2]ro...
Figure 12: Photoresponsive bending of artificial muscle with [c2]daisy chain reported by Harada and collaborat...
Figure 13: Light-responsive shuttling motion of [2]rotaxane based on a stiff-stilbene photoswitch. Figure 13 was reprod...
Figure 14: Azobenzene-based rotaxane modulating lipid bilayers upon photoisomerization. Figure 14 was adapted from [23] (© ...
Figure 15: Depiction of fluorescence quenching processes upon external stimuli of a dithienylethene-based [2]r...
Figure 16: Diagrammatic illustration of rotaxane 1-H-SP depicting interconversions between the four isomeric s...
Figure 17: Representation of [2]rotaxane chloride binding modulated by photoisomerization of a stiff-stilbene. ...
Comparative analysis of complanadine A total syntheses
- Reem Al-Ahmad and
- Mingji Dai
Beilstein J. Org. Chem. 2025, 21, 2334–2344, doi:10.3762/bjoc.21.178
- produce 11, which could be further converted to 12 and 13 for an intermolecular Mannich-type dimerization to form the C2–C3’ linkage [13]. Further oxidation state adjustment would give complanadines A, B, D, and E. Since their isolation, the complanadines, especially complanadine A, have attracted a
Graphical Abstract
Scheme 1: Complanadine natural products and their plausible biosynthesis.
Scheme 2: The Siegel total synthesis of complanadine A enabled by [2 + 2 + 2] cycloadditions.
Scheme 3: The Sarpong total synthesis of complanadine A enabled by a biomimetic strategy and C–H activation.
Scheme 4: The Tsukano total synthesis of complanadine A enabled by Diels–Alder cycloaddition, Heck cyclizatio...
Scheme 5: The Dai total synthesis of complanadine A using single-atom skeletal editing.
Scheme 6: Comparative summary of the four complanadine A total syntheses.
Recent advances in Norrish–Yang cyclization and dicarbonyl photoredox reactions for natural product synthesis
- Peng-Xi Luo,
- Jin-Xuan Yang,
- Shao-Min Fu and
- Bo Liu
Beilstein J. Org. Chem. 2025, 21, 2315–2333, doi:10.3762/bjoc.21.177
- economy of "one precursor for multiple targets", and provides a valuable scheme for building structurally diverse natural product libraries. 1.4 Gracilisoids A–I In 2025, Li's group exemplified the “Isolation-Synthesis-Functionality” research concept for a new class of sesterterpenoids, namely
Graphical Abstract
Scheme 1: a) The mechanism of Norrish type II reaction and Norrish–Yang cyclization; b) The mechanism of the ...
Scheme 2: Total synthesis of (+)-cyclobutastellettolide B.
Scheme 3: Norrish–Yang cyclization and 1,2-methyl migration.
Scheme 4: Synthetic study toward phainanoids.
Scheme 5: a) Mitsunobu reaction of the C9 ketal; b) Norrish–Yang cyclization of the saturated C5–C6; c) calcu...
Scheme 6: Total synthesis of avarane-type meroterpenoids.
Scheme 7: Total synthesis of gracilisoid A.
Scheme 8: Divergent total synthesis of gracilisoids B–I.
Scheme 9: Mechanism of the late-stage biomimetic photooxidation.
Scheme 10: Asymmetric total synthesis of lycoplatyrine A.
Scheme 11: Photoreaction of pyrrolidine-derived phenyl keto amide.
Scheme 12: Photoredox reactions of naphthoquinones.
Scheme 13: Synthetic study toward γ-rubromycin.
Scheme 14: Substituent-dependent conformational preferences.
Scheme 15: Total synthesis of preussomerins EG1, EG2, and EG3.
Pathway economy in cyclization of 1,n-enynes
- Hezhen Han,
- Wenjie Mao,
- Bin Lin,
- Maosheng Cheng,
- Lu Yang and
- Yongxiang Liu
Beilstein J. Org. Chem. 2025, 21, 2260–2282, doi:10.3762/bjoc.21.173
- 88, enabling its stable isolation and subsequent affordance of the spirocyclic indole-derived imine product 92 (Scheme 19, path b). The suppression of Wagner–Meerwein rearrangement was attributed to the lower Lewis acidity of PPh₃ relative to NFSI, which emerged as the critical determinant in this
Graphical Abstract
Scheme 1: Economical synthesis and pathway economy.
Scheme 2: Au(I)-catalyzed cascade cyclization paths of 1,5-enynes.
Scheme 3: Au(I)-catalyzed cyclization paths of 1,7-enynes.
Scheme 4: I2/TBHP-mediated radical cycloisomerization paths of 1,n-enyne.
Scheme 5: Au(I)-catalyzed cycloisomerization paths of 3-allyloxy-1,6-diynes.
Scheme 6: Pd(II)-catalyzed cycloisomerization paths of 2-alkynylbenzoate-cyclohexadienone.
Scheme 7: Stereoselective cyclization of 1,5-enynes.
Scheme 8: Substituent-controlled cycloisomerization of propargyl vinyl ethers.
Scheme 9: Au(I)-catalyzed pathway-controlled domino cyclization of 1,2-diphenylethynes.
Scheme 10: Au(I)-catalyzed tandem cyclo-isomerization of tryptamine-N-ethynylpropiolamide.
Scheme 11: Au(I)-catalyzed tunable cyclization of 1,6-cyclohexenylalkyne.
Scheme 12: Substituent-controlled 7-exo- and 8-endo-dig-selective cyclization of 2-propargylaminobiphenyl deri...
Scheme 13: BiCl3-catalyzed cycloisomerization of tryptamine-ynamide derivatives.
Scheme 14: Au(I)-mediated substituent-controlled cycloisomerization of 1,6-enynes.
Scheme 15: Ligand-controlled regioselective cyclization of 1,6-enynes.
Scheme 16: Ligand-dependent cycloisomerization of 1,7-enyne esters.
Scheme 17: Ligand-controlled cycloisomerization of 1,5-enynes.
Scheme 18: Ligand-controlled cyclization strategy of alkynylamide tethered alkylidenecyclopropanes.
Scheme 19: Ag(I)-mediated pathway-controlled cycloisomerization of tryptamine-ynamides.
Scheme 20: Gold-catalyzed cycloisomerization of indoles with alkynes.
Scheme 21: Catalyst-dependent cycloisomerization of dienol silyl ethers.
Scheme 22: Cycloisomerization of aromatic enynes governed by catalyst.
Scheme 23: Catalyst-dependent 1,2-migration in cyclization of 1-(indol-2-yl)-3-alkyn-1-ols.
Scheme 24: Gold-catalyzed cycloisomerization of N-propargyl-N-vinyl sulfonamides.
Scheme 25: Gold(I)-mediated enantioselective cycloisomerizations of ortho-(alkynyl)styrenes.
Scheme 26: Catalyst-controlled intramolecular cyclization of 1,7-enynes.
Scheme 27: Brønsted acid-catalyzed cycloisomerizations of tryptamine ynamides.
Scheme 28: Catalyst-controlled cyclization of indolyl homopropargyl amides.
Scheme 29: Angle strain-dominated 6-endo-trig cyclization of propargyl vinyl ethers.
Scheme 30: Angle strain-controlled cycloisomerization of alkyn-tethered indoles.
Scheme 31: Geometrical isomeration-dependent cycloisomerization of 1,3-dien-5-ynes.
Scheme 32: Temperature-controlled cyclization of 1,7-enynes.
Scheme 33: Cycloisomerizations of n-(o-ethynylaryl)acrylamides through temperature modulation.
Scheme 34: Temperature-controlled boracyclization of biphenyl-embedded 1,3,5-trien-7-ynes.
Pd-catalyzed dehydrogenative arylation of arylhydrazines to access non-symmetric azobenzenes, including tetra-ortho derivatives
- Loris Geminiani,
- Kathrin Junge,
- Matthias Beller and
- Jean-François Soulé
Beilstein J. Org. Chem. 2025, 21, 2234–2242, doi:10.3762/bjoc.21.170
- %, surpassing the performance of traditional approaches in similar contexts. Similarly, tri-ortho-substituted azobenzenes 5b and 5c were prepared in 42% and 47% yields, respectively. However, the isolation of these compounds in pure form remains challenging due to contamination with biphenyl side-products
Graphical Abstract
Figure 1: General overview of azobenzene chemistry. a) Selected examples and photoisomerization of azobenzene...
Scheme 1: Scope of aryl bromides in palladium-catalyzed dehydrogenative C–N coupling with phenylhydrazine (1a...
Scheme 2: Scope of arylhydrazines in palladium-catalyzed dehydrogenative C–N coupling with 2-bromotoluene (2a...
Scheme 3: Application to the synthesis of tetra-, tri or di-ortho-substituted azobenzenes via palladium-catal...
Figure 2: a) Proposed catalytic cycle for the one-pot palladium-catalyzed dehydrogenative C–N coupling for th...
C2 to C6 biobased carbonyl platforms for fine chemistry
- Jingjing Jiang,
- Muhammad Noman Haider Tariq,
- Florence Popowycz,
- Yanlong Gu and
- Yves Queneau
Beilstein J. Org. Chem. 2025, 21, 2103–2172, doi:10.3762/bjoc.21.165
- oxidation without isolation) produce 5,5'-oxybis(furan-2(5H)-one) and 5,5 '-(oxybis(methylene))bis-2-furfural [127][128][129] (Scheme 42, path a). The antimicrobial agent 5-chloro-2(5H)-furanone was synthesized by reaction of HFO with thionyl chloride in 30% yield [130], or with phosphorus chloride in 70
Graphical Abstract
Figure 1: C2–C6 biobased carbonyl building blocks.
Scheme 1: Proposed (2 + 2) route to glycolaldehyde and glycolic acid from erythritol by Cu/AC catalyst (AC = ...
Scheme 2: Reductive amination of GCA.
Scheme 3: N-Formylation of secondary amines by reaction with GCA.
Scheme 4: Synthesis and conversion of hydroxy acetals to cyclic acetals.
Scheme 5: Synthesis of 3-(indol-3-yl)-2,3-dihydrofurans via three-component reaction of glycolaldehyde, indol...
Scheme 6: BiCl3-catalyzed synthesis of benzo[a]carbazoles from 2-arylindoles and α-bromoacetaldehyde ethylene...
Scheme 7: Cu/NCNSs-based conversion of glycerol to glycolic acid and other short biobased acids.
Scheme 8: E. coli-based biotransformation of C1 source molecules (CH4, CO2 and CO) towards C2 glycolic acid.
Scheme 9: N-Formylation of amines with C2 (a) or C3 (b) biomass-based feedstocks.
Scheme 10: Methods for the formation of propanoic acid (PA) from lactic acid (LA).
Scheme 11: Co-polymerization of biobased lactic acid and glycolic acid via a bicatalytic process.
Scheme 12: Oxidation of α-hydroxy acids by tetrachloroaurate(III) in acetic acid–sodium acetate buffer medium.
Figure 2: Selective catalytic pathways for the conversion of lactic acid (LA).
Scheme 13: Synthesis of 1,3-PDO via cross-aldol reaction between formaldehyde and acetaldehyde to 3-hydroxypro...
Scheme 14: Hydrothermal conversion of 1,3-dihydroxy-2-propane and 2,3-dihydroxypropanal to methylglyoxal.
Scheme 15: FLS-catalyzed formose reaction to synthesize GA and DHA.
Scheme 16: GCA and DHA oxidation products of glycerol and isomerization of GCA to DHA under flow conditions us...
Scheme 17: Acid-catalyzed reactions of DHA with alcohols.
Scheme 18: Synthesis of dihydroxyacetone phosphate from dihydroxyacetone.
Scheme 19: Bifunctional acid–base catalyst DHA conversion into lactic acid via pyruvaldehyde or fructose forma...
Scheme 20: Catalytic one-pot synthesis of GA and co-synthesis of formamides and formates from DHA.
Scheme 21: (a) Synthesis of furan derivatives and (b) synthesis of thiophene derivative by cascade [3 + 2] ann...
Scheme 22: Brønsted acidic ionic liquid catalyzed synthesis of benzo[a]carbazole from renewable acetol and 2-p...
Scheme 23: Asymmetric hydrogenation of α-hydroxy ketones to 1,2-diols.
Scheme 24: Synthesis of novel 6-(substituted benzylidene)-2-methylthiazolo [2,3-b]oxazol-5(6H)-one from 1-hydr...
Scheme 25: ʟ-Proline-catalyzed synthesis of anti-diols from hydroxyacetone and aldehydes.
Scheme 26: C–C-bond-formation reactions of a biomass-based feedstock aromatic aldehyde (C5) and hydroxyacetone...
Scheme 27: Ethanol upgrading to C4 bulk chemicals via the thiamine (VB1)-catalyzed acetoin condensation.
Scheme 28: One-pot sequential chemoenzymatic synthesis of 2-aminobutane-1,4-diol and 1,2,4-butanetriol via 1,4...
Scheme 29: Synthesis of 1,4-dihydroxybutan-2-one by microbial transformation.
Scheme 30: Conversion of polyols by [neocuproine)Pd(OAc)]2(OTf)2] to α-hydroxy ketones.
Scheme 31: Chemoselective oxidation of alcohols with chiral palladium-based catalyst 2.
Scheme 32: Electrochemical transformation of furfural to 5-hydroxy-2(5H)-furanone (HFO).
Scheme 33: Selective hydrodeoxygenation of HFO and oxidation to γ-butyrolactone (GBL).
Scheme 34: Photosensitized oxygenation of furan towards HFO via ozonide intermediates.
Scheme 35: Conversion of furfural to HFO and MAN by using mesoporous carbon nitride (SGCN) as photocatalyst.
Scheme 36: Synthesis of HFO from furan derivatives.
Scheme 37: Photooxidation of furfural to 5-hydroxy-2(5H)-furanone (HFO).
Scheme 38: Synthesis of Friedel–Crafts indole adduct from HFO.
Scheme 39: Conversion of HFO to α,γ-substituted chiral γ-lactones.
Scheme 40: Tautomeric transformation of HFO to formylacrylic acid.
Scheme 41: Hydrolysis of HFO to succinic acid in aqueous solution.
Scheme 42: Substitution and condensation reactions of 5-hydroxy-2(5H)-furanone (HFO).
Scheme 43: (a) Conversion of HFO towards valuable C4 chemicals and (b) anodic oxidation of 5-hydroxy-2(5H)-fur...
Figure 3: Conversion of HFO towards other natural and synthetic substances.
Scheme 44: Conversion of furfural to maleic anhydride (reaction a: VOx/Al2O3; reaction b: VPO).
Scheme 45: Conversion of furfural into succinic acid.
Scheme 46: Electro‑, photo‑, and biocatalysis for one-pot selective conversions of furfural into C4 chemicals.
Scheme 47: Production route of furfural from hemicellulose.
Scheme 48: Mechanism for xylose dehydration to furfural through a choline xyloside intermediate.
Scheme 49: Conversion of furfural to furfuryl alcohol and its derivatives.
Scheme 50: Conversion of furfural to furfuryl alcohol and 3-(2-furyl)acrolein.
Scheme 51: The aerobic oxidative condensation of biomass-derived furfural and linear alcohols.
Scheme 52: The single-step synthesis of 2-pentanone from furfural.
Scheme 53: Electrocatalytic coupling reaction of furfural and levulinic acid.
Scheme 54: Conversion of furfural to m-xylylenediamine.
Scheme 55: Conversion of furfural to tetrahydrofuran-derived amines.
Scheme 56: Formation of trans-4,5-diamino-cyclopent-2-enones from furfural.
Scheme 57: Production of pyrrole and proline from furfural.
Scheme 58: Synthesis of 1‑(trifluoromethyl)-8-oxabicyclo[3.2.1]oct-3-en-2-ones from furfural.
Scheme 59: Conversion of furfural to furfural-derived diacids.
Scheme 60: A telescope protocol derived from furfural and glycerol.
Scheme 61: A tandem cyclization of furfural and 5,5-dimethyl-1,3-cyclohexanedione.
Scheme 62: A Ugi four-component reaction to construct furfural-based polyamides.
Scheme 63: One-pot synthesis of γ-acyloxy-Cy7 from furfural.
Scheme 64: Dimerization–Piancatelli sequence toward humins precursors from furfural.
Scheme 65: Conversion of furfural to CPN.
Scheme 66: Synthesis of jet fuels range cycloalkanes from CPN and lignin-derived vanillin.
Scheme 67: Solar-energy-driven synthesis of high-density biofuels from CPN.
Scheme 68: Reductive amination of CPN to cyclopentylamine.
Scheme 69: Asymmetric hydrogenation of C=O bonds of exocyclic α,β-unsaturated cyclopentanones.
Scheme 70: Preparation of levulinic acid via the C5 route (route a) or C6 route (routes b1 and b2).
Scheme 71: Mechanism of the rehydration of HMF to levulinic acid and formic acid.
Scheme 72: Important levulinic acid-derived chemicals.
Scheme 73: Direct conversion of levulinic acid to pentanoic acid.
Scheme 74: Catalytic aerobic oxidation of levulinic acid to citramalic acid.
Scheme 75: Conversion of levulinic acid to 1,4-pentanediol (a) see ref. [236]; b) see ref. [237]; c) see ref. [238]; d) see r...
Scheme 76: Selective production of 2-butanol through hydrogenolysis of levulinic acid.
Scheme 77: General reaction pathways proposed for the formation of 5MPs from levulinic acid.
Scheme 78: Selective reductive amination of levulinic acid to N-substituted pyrroles.
Scheme 79: Reductive amination of levulinic acid to chiral pyrrolidinone.
Scheme 80: Reductive amination of levulinic acid to non-natural chiral γ-amino acid.
Scheme 81: Nitrogen-containing chemicals derived from levulinic acid.
Scheme 82: Preparation of GVL from levulinic acid by dehydration and hydrogenation.
Scheme 83: Ruthenium-catalyzed levulinic acid to chiral γ-valerolactone.
Scheme 84: Catalytic asymmetric hydrogenation of levulinic acid to chiral GVL.
Scheme 85: Three steps synthesis of ε-caprolactam from GVL.
Scheme 86: Multistep synthesis of nylon 6,6 from GVL.
Scheme 87: Preparation of MeGVL by α-alkylation of GVL.
Scheme 88: Ring-opening polymerization of five-membered lactones.
Scheme 89: Synthesis of GVL-based ionic liquids.
Scheme 90: Preparation of butene isomers from GVL under Lewis acid conditions.
Scheme 91: Construction of C5–C12 fuels from GVL over nano-HZSM-5 catalysts.
Scheme 92: Preparation of alkyl valerate from GVL via ring opening/reduction/esterification sequence.
Scheme 93: Construction of 4-acyloxypentanoic acids from GVL.
Scheme 94: Synthesis of 1,4-pentanediol (PDO) from GVL.
Scheme 95: Construction of novel cyclic hemiketal platforms via self-Claisen condensation of GVL.
Scheme 96: Copper-catalyzed lactamization of GVL.
Figure 4: Main scaffolds obtained from HMF.
Scheme 97: Biginelli reactions towards HMF-containing dihydropyrimidinones.
Scheme 98: Hantzsch dihydropyridine synthesis involving HMF.
Scheme 99: The Kabachnik–Fields reaction involving HMF.
Scheme 100: Construction of oxazolidinone from HMF.
Scheme 101: Construction of rhodamine-furan hybrids from HMF.
Scheme 102: A Groebke–Blackburn–Bienaymé reaction involving HMF.
Scheme 103: HMF-containing benzodiazepines by [4 + 2 + 1] cycloadditions.
Scheme 104: Synthesis of fluorinated analogues of α-aryl ketones.
Scheme 105: Synthesis of HMF derived disubstituted γ-butyrolactone.
Scheme 106: Functionalized aromatics from furfural and HMF.
Scheme 107: Diels–Alder adducts from HMF or furfural with N-methylmaleimide.
Scheme 108: Pathway of the one-pot conversion of HMF into phthalic anhydride.
Scheme 109: Photocatalyzed preparation of humins (L-H) from HMF mixed with spoiled HMF residues (LMW-H) and fur...
Scheme 110: Asymmetric dipolar cycloadditions on HMF.
Scheme 111: Dipolar cycloadditions of HMF based nitrones to 3,4- and 3,5-substituted isoxazolidines.
Scheme 112: Production of δ-lactone-fused cyclopenten-2-ones from HMF.
Scheme 113: Aza-Piancatelli access to aza-spirocycles from HMF-derived intermediates.
Scheme 114: Cross-condensation of furfural, acetone and HMF into C13, C14 and C15 products.
Scheme 115: Base-catalyzed aldol condensation/dehydration sequences from HMF.
Scheme 116: Condensation of HMF and active methylene nitrile.
Scheme 117: MBH reactions involving HMF.
Scheme 118: Synthesis of HMF-derived ionic liquids.
Scheme 119: Reductive amination/enzymatic acylation sequence towards HMF-based surfactants.
Scheme 120: The formation of 5-chloromethylfurfural (CMF).
Scheme 121: Conversion of CMF to HMF, levulinic acid, and alkyl levulinates.
Scheme 122: Conversion of CMF to CMFCC and FDCC.
Scheme 123: Conversion of CMF to BHMF.
Scheme 124: Conversion of CMF to DMF.
Scheme 125: CMF chlorine atom substitutions toward HMF ethers and esters.
Scheme 126: Introduction of carbon nucleophiles in CMF.
Scheme 127: NHC-catalyzed remote enantioselective Mannich-type reactions of CMF.
Scheme 128: Conversion of CMF to promising biomass-derived dyes.
Scheme 129: Radical transformation of CMF with styrenes.
Scheme 130: Synthesis of natural herbicide δ-aminolevulinic acid from CMF.
Scheme 131: Four step synthesis of the drug ranitidine from CMF.
Scheme 132: Pd/CO2 cooperative catalysis for the production of HHD and HXD.
Scheme 133: Different ruthenium (Ru) catalysts for the ring-opening of 5-HMF to HHD.
Scheme 134: Proposed pathways for preparing HXD from HMF.
Scheme 135: MCP formation and uses.
Scheme 136: Cu(I)-catalyzed highly selective oxidation of HHD to 2,5-dioxohexanal.
Scheme 137: Synthesis of N‑substituted 3‑hydroxypyridinium salts from 2,5-dioxohexanal.
Scheme 138: Ru catalyzed hydrogenations of HHD to 1,2,5-hexanetriol (a) see ref. [396]; b) see ref. [397]).
Scheme 139: Aviation fuel range quadricyclanes produced by HXD.
Scheme 140: Synthesis of HDGK from HXD and glycerol as a chain extender.
Scheme 141: Synthesis of serinol pyrrole from HXD and serinol.
Scheme 142: Synthesis of pyrroles from HXD and nitroarenes.
Scheme 143: Two-step production of PX from cellulose via HXD.
Scheme 144: Preparation of HCPN from HMF via hydrogenation and ring rearrangement.
Scheme 145: Suggested pathways from HMF to HCPN.
Scheme 146: α-Alkylation of HCPN with ethylene gas.
Scheme 147: Synthesis of 3-(hydroxymethyl)cyclopentylamine from HMF via reductive amination of HCPN.
Scheme 148: Production of LGO and Cyrene® from biomass.
Scheme 149: Synthesis of HBO from LGO and other applications.
Scheme 150: Construction of m-Cyrene® homopolymer.
Scheme 151: Conversion of Cyrene® to THFDM and 1,6-hexanediol.
Scheme 152: RAFT co-polymerization of LGO and butadienes.
Scheme 153: Polycondensation of HO-LGOL and diols with dimethyl adipate.
Scheme 154: Self-condensation of Cyrene® and Claisen–Schmidt reactions.
Scheme 155: Synthesis of 5-amino-2-(hydroxymethyl)tetrahydropyran from Cyrene®.
The application of desymmetric enantioselective reduction of cyclic 1,3-dicarbonyl compounds in the total synthesis of terpenoid and alkaloid natural products
- Dong-Xing Tan and
- Fu-She Han
Beilstein J. Org. Chem. 2025, 21, 2085–2102, doi:10.3762/bjoc.21.164
- Hamigera tarangaensis, and show cytotoxicity against various tumor cells. Notably, compound 11 exhibits 100% inhibition against herpes and polio viruses without significant host cell cytotoxicity [38]. Since their isolation, the synthesis of 11 and 12 have been reported by many groups [39][40][41][42][43
Graphical Abstract
Figure 1: Several representative terpenoid and alkaloid natural products synthesized by applying desymmetric ...
Figure 2: Selected terpenoid and alkaloid natural products synthesized by applying desymmetric enantioselecti...
Scheme 1: The total synthesis of (+)-aplysiasecosterol A (6) by Li [14].
Scheme 2: The total synthesis of (−)-cyrneine A by Han [31].
Scheme 3: The total syntheses of three cyrneine diterpenoids by Han [31,32].
Scheme 4: The total synthesis of (−)-hamigeran B and (−)-4-bromohamigeran B by Han [51].
Scheme 5: The total synthesis of (+)-randainin D by Baudoin [53].
Scheme 6: The total synthesis of (−)-hunterine A and (−)-aspidospermidine by Stoltz [58].
Scheme 7: The total synthesis of (+)-toxicodenane A by Han [65,66].
Scheme 8: The formal total synthesis of (−)-conidiogeone B and total synthesis of (−)-conidiogeone F by Lee a...
Scheme 9: The total syntheses of four conidiogenones natural products by Lee and Han [72].
Scheme 10: The total synthesis of (−)-platensilin by Lou and Xu [82].
Scheme 11: The total synthesis of (−)-platencin and (−)-platensimycin by Lou and Xu [82].
Scheme 12: The total synthesis of (+)-isochamaecydin and (+)-chamaecydin by Han [86].
Further elaboration of the stereodivergent approach to chaetominine-type alkaloids: synthesis of the reported structures of aspera chaetominines A and B and revised structure of aspera chaetominine B
- Jin-Fang Lü,
- Jiang-Feng Wu,
- Jian-Liang Ye and
- Pei-Qiang Huang
Beilstein J. Org. Chem. 2025, 21, 2072–2081, doi:10.3762/bjoc.21.162
- fungus Aspergillus versicolour SCSIO XWS04 F52 [32]. All these alkaloids distinguish each other only by alkyl substituent at C11 and by relative stereochemistries at C2, C3, C11, and C14. Soon after the report of the isolation, structural elucidation, and bioactivity of (–)-chaetominine by Tan and co
- structures of aspera chaetominines A and B and revision of stereochemistry of aspera chaetominine B Several years after we have had accomplished the abovementioned investigations, Liu and co-workers reported the isolation and structural elucidation of two new alkaloids, aspera chaetominines A (12) and B (13
Graphical Abstract
Figure 1: Structures of some reported chaetominine-type alkaloids and revised structures via our total synthe...
Scheme 1: Improved total synthesis of (–)-isochaetominine A (4) and diastereomer 16.
Scheme 2: Diastereoconvergent transformations of 17 and 18 into two diastereomers of versiquinazoline H.
Scheme 3: Mono- and double epimerization-based enantiodivergent syntheses of chaetominine-type alkaloids and ...
Scheme 4: Enantioselective synthesis of the proposed structure of aspera chaetominine A.
Scheme 5: Enantioselective syntheses of both the proposed and revised structures of aspera chaetominine B.
Bioinspired total syntheses of natural products: a personal adventure
- Zhengyi Qin,
- Yuting Yang,
- Nuran Yan,
- Xinyu Liang,
- Zhiyu Zhang,
- Yaxuan Duan,
- Huilin Li and
- Xuegong She
Beilstein J. Org. Chem. 2025, 21, 2048–2061, doi:10.3762/bjoc.21.160
- propose the biosynthetic pathway, which has not yet been reported in Duh’s isolation report (Scheme 1a). In our proposal, the linear sesquiterpenoid trans-nerolidol (1) with a chiral tertiary alcohol undergoes dihydroxylation to generate triol 2, which further proceeds a C–C bond cleavage to afford
- rearrangement under the conditions of H2SO4/MeOH, since their isolation of the natural products [32]. However, other critical bioinspired transformations have not yet been explored, which prompted us to initiate this study. Guided by this biogenetic proposal, we conducted a series of reactions to probe the
Graphical Abstract
Figure 1: Representative natural products with biomimetic total synthesis.
Scheme 1: Bioinspired total synthesis of chabranol (2010).
Scheme 2: Proposed biosynthetic pathway of monocerin-family natural products.
Scheme 3: Bioinspired total synthesis of monocerin-family molecules (2013).
Scheme 4: Bioinspired skeletal diversification of (12-MeO-)tabertinggine (2016).
Scheme 5: Structures and our proposed biosynthetic pathway of gymnothelignans.
Scheme 6: Bioinspired total synthesis of gymnothelignans (2014–2025).
Scheme 7: Bioinspired total synthesis of sarglamides (2025).
Switchable pathways of multicomponent heterocyclizations of 5-amino-1,2,4-triazoles with salicylaldehydes and pyruvic acid
- Yana I. Sakhno,
- Oleksander V. Buravov,
- Kostyantyn Yu. Yurkov,
- Anastasia Yu. Andryushchenko,
- Svitlana V. Shishkina and
- Valentyn A. Chebanov
Beilstein J. Org. Chem. 2025, 21, 2030–2035, doi:10.3762/bjoc.21.158
- also was described in several other publications [13][14][15]. On the other hand, three-component reactions of aminoazoles, salicylaldehyde, and esters (or amides) of acetoacetic acid with isolation of other types of heterocylic compounds were described in some papers [16][17]. Our early works were
Graphical Abstract
Scheme 1: Diversity of heterocyclization products from reaction of aminoazoles with salicylaldehydes, and pyr...
Scheme 2: MCRs of 3-amino-5-methylthio-1,2,4-triazole (1a) and 3-amino-5-methoxy-1,2,4-triazole (1b) with sal...
Scheme 3: MCRs of 3-amino-5-methylthio-1,2,4-triazole (1a), salicylaldehydes 2a–c,f, and pyruvic acid (3) und...
Figure 1: Molecular structure of compound 4c according to X-ray diffraction data. Thermal ellipsoids are show...
